Also consistent with our result, different randomized interventional studies have demonstrated the benefits of MD, compared to other nutritional interventions on insulin-resistant improvement in obese and overweight patients and in patients with metabolic syndrome and NAFLD [9,24]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.